- Home
- CZNC vs ABSI Comparison
CZNC vs ABSI Comparison
Compare CZNC & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- ABSI
- Stock Information
- Founded
- CZNC 1864
- ABSI 2011
- Country
- CZNC United States
- ABSI United States
- Employees
- CZNC N/A
- ABSI N/A
- Industry
- CZNC Major Banks
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CZNC Finance
- ABSI Health Care
- Exchange
- CZNC Nasdaq
- ABSI Nasdaq
- Market Cap
- CZNC 330.3M
- ABSI 318.2M
- IPO Year
- CZNC N/A
- ABSI 2021
- Fundamental
- Price
- CZNC $20.21
- ABSI $3.14
- Analyst Decision
- CZNC
- ABSI Strong Buy
- Analyst Count
- CZNC 0
- ABSI 7
- Target Price
- CZNC N/A
- ABSI $8.57
- AVG Volume (30 Days)
- CZNC 24.3K
- ABSI 5.0M
- Earning Date
- CZNC 05-06-2025
- ABSI 03-18-2025
- Dividend Yield
- CZNC 5.55%
- ABSI N/A
- EPS Growth
- CZNC 7.45
- ABSI N/A
- EPS
- CZNC 1.69
- ABSI N/A
- Revenue
- CZNC $106,129,000.00
- ABSI $4,207,000.00
- Revenue This Year
- CZNC $9.38
- ABSI $7.92
- Revenue Next Year
- CZNC $3.77
- ABSI $162.34
- P/E Ratio
- CZNC $11.99
- ABSI N/A
- Revenue Growth
- CZNC 1.43
- ABSI N/A
- 52 Week Low
- CZNC $16.50
- ABSI $2.45
- 52 Week High
- CZNC $22.68
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- CZNC 45.25
- ABSI 39.74
- Support Level
- CZNC $19.58
- ABSI $2.90
- Resistance Level
- CZNC $20.51
- ABSI $3.26
- Average True Range (ATR)
- CZNC 0.49
- ABSI 0.31
- MACD
- CZNC -0.14
- ABSI -0.12
- Stochastic Oscillator
- CZNC 32.14
- ABSI 17.74
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.